Title
Reporting Intellectual Capital and Measuring its Performance: The Case Of Romanian Public Companies,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 3–5 business days
- Estimated Delivery: 6–10 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
The main objectives of this material are: (1) to analyse the extend to which Romanian public companies disclose information related to intellectual capital (IC); (2) to analyse if company size and industry type may have determined the level of disclosure in the case of Romanian public companies; (3) to analyse whether there is any correlation between intellectual capital performance and traditional companies performance in the case of Romanian public companies. The findings show that intellectual capital disclosures (ICD) made by Romanian companies are most of qualitative in nature; that internal capital is the most frequently disclosed IC category; there is no association between the level of ICD and company size, ICD and industry type, and ICD and any combination between company size and industry type. The results obtained represent a basis for comparison with those obtained by other studies and helps understanding the implications on the business performance of the Romanian listed companies from an IC perspective. This is a pioneering study in the case of Romanian listed companies enriching IC literature with new empirical evidence.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.